Compare Smith & Nephew plc (SNN) vs Vanguard Emerging Markets Stock Index Fund ETF (VWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Vanguard Emerging Markets Stock Index Fund ETF — how do they compare? Smith & Nephew plc trades at $27.96 (market cap $11.62B), while Vanguard Emerging Markets Stock Index Fund ETF trades at $60.56. The key difference: Smith & Nephew plc pays a 2.86% dividend while Vanguard Emerging Markets Stock Index Fund ETF pays none, and Vanguard Emerging Markets Stock Index Fund ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | VWO | |
|---|---|---|
Market Cap | $11.62B | — |
Sector | Health | — |
52-Week High | $38.53 | $61.44 |
52-Week Low | $27.80 | $52.42 |
Enterprise Value | $14.66B | — |
Dividend Yield | 2.86% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
VWO trades at $61.245, down 0.32% today, with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights strong institutional buying and emerging market ETF inflows, with a dividend scheduled for June 2026. The fund's low expense ratio of 0.06% and focus on developing economies attract cost-conscious investors seeking diversification.
Outlook remains positive due to institutional accumulation and emerging market growth potential, but risks include currency volatility and China's economic influence. The neutral RSI suggests limited near-term momentum, while ADX indicates a strengthening trend. Investors benefit from broad exposure but face geopolitical and concentration risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →
